CXCR-4 desensitization is associated with tissue localization of hemopoietic progenitor cells

被引:124
作者
Shen, HM
Cheng, T
Olszak, I
Garcia-Zepeda, E
Lu, ZJ
Herrmann, S
Fallon, R
Luster, AD
Scadden, DT
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, AIDS Res Ctr,Canc Ctr, Boston, MA 02129 USA
[2] St Louis Univ, St Louis, MO 63103 USA
关键词
D O I
10.4049/jimmunol.166.8.5027
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The chemokine stroma-derived factor (SDF)-1, and its receptor, CXCR-4, have been shown to be essential for the translocation of hemopoietic stern cells from the fetal liver to the bone marrow (BM). We hypothesized that if CXCR-4 plays a crucial role in the localization of human hemopoiesis, stem cells from distinct tissue sources should demonstrate distinct CXCR-4 expression or signaling profiles. CD34(+) cells from BM were compared with blood: either mobilized peripheral blood or umbilical cord blood. Unexpectedly, significantly higher levels of CXCR-4 surface expression on CD34(+) cells from blood sources, mobilized peripheral blood, or cord blood were observed compared with BM (p = 0.0005 and p = 0.002, respectively). However, despite lower levels of CXCR-4, responsiveness of the cells to SDF-1 as measured by either calcium flux or transmigration was proportionally greatest in cells derived from BM. Further, internalization of CXCR-4 in response to ligand, associated with receptor desensitization, was significantly lower on BM-derived cells. Therefore, preserved chemokine receptor signaling was highly associated with marrow rather than blood localization. To test the functional effects of perturbing CXCR-4 signaling, adult mice were exposed to the niethionine-SDF-1 beta analog that induces prolonged down-regulation/desensitization of CXCR-4 and observed mobilization of Lin(-), Sca-1(+), Thy-1(low), and c-kit(+) hemopoietic progenitor cells to the peripheral blood with a > 30-fold increase compared with PBS control (p = 0.0007 day 1 and p = 0.004 day 2). These data demonstrate that CXCR-4 expression and function can be dissociated in progenitor cells and that desensitization of CXCR-4 induces stem cell entry into the circulation. The Journal of Immunology.
引用
收藏
页码:5027 / 5033
页数:7
相关论文
共 27 条
[1]   The chemokine SDF-1 is a chemoattractant for human CD34(+) hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34(+) progenitors to peripheral blood [J].
Aiuti, A ;
Webb, IJ ;
Bleul, C ;
Springer, T ;
GutierrezRamos, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (01) :111-120
[2]  
Aiuti A, 1999, EUR J IMMUNOL, V29, P1823, DOI 10.1002/(SICI)1521-4141(199906)29:06<1823::AID-IMMU1823>3.0.CO
[3]  
2-B
[4]   Human CD34+ cells express CXCR4 and its ligand stromal cell-derived factor-1.: Implications for infection by T-cell tropic human immunodeficiency virus [J].
Aiuti, A ;
Turchetto, L ;
Cota, M ;
Cipponi, A ;
Brambilla, A ;
Arcelloni, C ;
Paroni, R ;
Vicenzi, E ;
Bordignon, C ;
Poli, G .
BLOOD, 1999, 94 (01) :62-73
[5]   A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) [J].
Bleul, CC ;
Fuhlbrigge, RC ;
Casasnovas, JM ;
Aiuti, A ;
Springer, TA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :1101-1109
[6]   Expression of the human immunodeficiency virus type-1 coreceptors CXCR-4 (fusin, LESTR) and CKR-5 in CD34(+) hematopoietic progenitor cells [J].
Deichmann, M ;
Kronenwett, R ;
Haas, R .
BLOOD, 1997, 89 (10) :3522-3528
[7]   A 48-WELL MICRO CHEMOTAXIS ASSEMBLY FOR RAPID AND ACCURATE MEASUREMENT OF LEUKOCYTE MIGRATION [J].
FALK, W ;
GOODWIN, RH ;
LEONARD, EJ .
JOURNAL OF IMMUNOLOGICAL METHODS, 1980, 33 (03) :239-247
[8]   Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization [J].
Ferguson, SSG ;
Downey, WE ;
Colapietro, AM ;
Barak, LS ;
Menard, L ;
Caron, MG .
SCIENCE, 1996, 271 (5247) :363-366
[9]   G-protein-coupled receptor regulation: Role of G-protein-coupled receptor kinases and arrestins [J].
Ferguson, SSG ;
Barak, LS ;
Zhang, J ;
Caron, MG .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1996, 74 (10) :1095-1110
[10]  
GarciaZepeda EA, 1996, J IMMUNOL, V157, P5613